Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Isoamyl 5,6-dihydro-7,8-dimethyl-4,5-dioxo-4h-pyrano(3,2-c)quinoline -2-carboxylate
2. My 5116
3. My-5116
1. 73080-51-0
2. Romet
3. My-5116
4. Isopentyl 7,8-dimethyl-4,5-dioxo-5,6-dihydro-4h-pyrano[3,2-c]quinoline-2-carboxylate
5. 3-methylbutyl 7,8-dimethyl-4,5-dioxo-6h-pyrano[3,2-c]quinoline-2-carboxylate
6. 4k8ka8b61g
7. Repirinastum
8. Repirinastum [inn-latin]
9. 3-methylbutyl 5-hydroxy-7,8-dimethyl-4-oxopyrano[3,2-c]quinoline-2-carboxylate
10. Repirinast [usan:inn:jan]
11. Brn 4267921
12. Unii-4k8ka8b61g
13. Repirinast-[d4]
14. Isoamyl 5,6-dihydro-7,8-dimethyl-4,5-dioxo-4h-pyrano(3,2-c)quinoline-2-carboxylate
15. Romet (tn)
16. Repirinast [mi]
17. Repirinast [inn]
18. Repirinast [jan]
19. Repirinast [usan]
20. Repirinast [mart.]
21. Isopentyl 5,6-dihydro-7,8-dimethyl-4,5-dioxo-4h-pyrano(3,2-c)quinoline-2-carboxylate
22. Repirinast [who-dd]
23. Schembl29997
24. Repirinast (jan/usan/inn)
25. Chembl2105300
26. Chebi:32092
27. Dtxsid10223349
28. Zinc538285
29. Bcp16315
30. Ex-a3508
31. My5116
32. Akos016014130
33. Ac-5020
34. 4h-pyrano(3,2-c)quinoline-2-carboxylic Acid, 5,6-dihydro-7,8-dimethyl-4,5-dioxo-, 3-methylbutyl Ester
35. 4h-pyrano(3,2-c)quinoline-2-carboxylic Acid, 5,6-dihydro-7,8-dimethyl-4,5-dioxo-, Isopentyl Ester
36. Db-055720
37. Hy-109544
38. Cs-0031286
39. Ft-0630818
40. D01890
41. 080r510
42. A837709
43. Q7314016
| Molecular Weight | 355.4 g/mol |
|---|---|
| Molecular Formula | C20H21NO5 |
| XLogP3 | 3.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 5 |
| Exact Mass | 355.14197277 g/mol |
| Monoisotopic Mass | 355.14197277 g/mol |
| Topological Polar Surface Area | 81.7 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 690 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Immunosuppressive Agents
Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)
Histamine Antagonists
Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. (See all compounds classified as Histamine Antagonists.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
REF. STANDARDS & IMPURITIES
USP
ABOUT THIS PAGE
A Repirinast manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Repirinast, including repackagers and relabelers. The FDA regulates Repirinast manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Repirinast API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Repirinast manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Repirinast supplier is an individual or a company that provides Repirinast active pharmaceutical ingredient (API) or Repirinast finished formulations upon request. The Repirinast suppliers may include Repirinast API manufacturers, exporters, distributors and traders.
click here to find a list of Repirinast suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Repirinast DMF (Drug Master File) is a document detailing the whole manufacturing process of Repirinast active pharmaceutical ingredient (API) in detail. Different forms of Repirinast DMFs exist exist since differing nations have different regulations, such as Repirinast USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Repirinast DMF submitted to regulatory agencies in the US is known as a USDMF. Repirinast USDMF includes data on Repirinast's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Repirinast USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Repirinast suppliers with USDMF on PharmaCompass.
Repirinast Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Repirinast GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Repirinast GMP manufacturer or Repirinast GMP API supplier for your needs.
A Repirinast CoA (Certificate of Analysis) is a formal document that attests to Repirinast's compliance with Repirinast specifications and serves as a tool for batch-level quality control.
Repirinast CoA mostly includes findings from lab analyses of a specific batch. For each Repirinast CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Repirinast may be tested according to a variety of international standards, such as European Pharmacopoeia (Repirinast EP), Repirinast JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Repirinast USP).
LOOKING FOR A SUPPLIER?
